FDA, COVID-19 and vaccine
Digest more
Liquidia Corporation (NASDAQ:LQDA) announced today that the U.S. Food and Drug Administration (FDA) has approved YUTREPIA (treprostinil) inhalation powder for adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South Korea may be potentially contaminated with norovirus.
The FDA approved three natural food additives. Food and nutrition experts share what that means for families and our food supply.
"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical and scientific information on several important topics. At this roundtable,
A joint operation conducted by the Food and Drug Administration and Customs and Border Protection resulted in the seizure of nearly 2 million illegal electronic cigarettes, most of which came from China .
The FDA is embracing natural colorants, with three approvals meant to replace synthetic dyes. Galdieria extract, butterfly pea flower, and calcium phosphate are now allowed in a range of foods. This is a key step in the pivot from artificial additives.
The U.S. Food and Drug Administration (FDA) has announced a new initiative to systematically review the safety of chemicals already in the
The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,
The U.S. Food and Drug Administration announced Friday it has granted three new color additive petitions to expand the available colors from natural sources.
In his first major public remarks as commissioner of the U.S. Food and Drug Administration, Dr. Marty Makary laid out a comprehensive,
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as "smoker's lung", the company said on Thursday.